A Case of a Lethal Diquat Ingestion in a Toddler

Manette Ness-Cochinwala1, Juan Sebastian Proaño1, Jeffery N Bernstein2

  • 1Division of Critical Care Medicine, Nicklaus Children's Hospital, Miami, Florida; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida.

Insights

Diquat herbicide poisoning can cause severe multisystem organ failure, even in children. Early gastric decontamination is crucial for emergency physicians managing diquat toxicity cases.

Area of Science:

  • Toxicology
  • Pediatric Emergency Medicine
  • Environmental Health

Background:

  • Diquat is a potent herbicide known for rapid and severe systemic toxicity.
  • It can lead to multisystem organ failure affecting the gastrointestinal, renal, cardiovascular, and central nervous systems.
  • Reported case fatality rates for diquat poisoning can be as high as 43%.

Observation:

  • A pediatric case of diquat ingestion resulting in multisystem organ failure and death is presented.
  • This case highlights the extreme toxicity of diquat, particularly in the pediatric population.
  • Even small quantities of diquat can be lethal for children.

Findings:

  • Diquat poisoning can rapidly progress to life-threatening conditions.
  • The primary mechanisms of toxicity involve multiple organ systems.
  • Pediatric literature on diquat poisoning remains limited, underscoring the importance of case reports.

Implications:

  • Emergency physicians must be aware of diquat's significant morbidity and mortality potential.
  • Prompt gastric decontamination is the only currently proven therapeutic strategy for diquat poisoning.
  • This case emphasizes the critical need for vigilance and rapid intervention in suspected pediatric diquat exposures.
Abstract

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
957
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
33
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
18
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K